Company Overview and News

 
Emmerson Resources announces 'one of most exciting deals ever at Tennant Creek'

2018-09-06 proactiveinvestors.com.au
The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.
ERM EMMRF

 
Emmerson Resources forms transformational alliance, raises cash at 56% premium

2018-09-06 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) has finalised a game-changing strategic alliance with a subsidiary of Territory Resources Ltd (ASX:TTY).
ERM EMMRF

 
Emmerson Resources announces 'one of most exciting deals ever at Tennant Creek'

2018-09-04 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director & CEO Rob Bills visits the Proactive Investors Perth studio to discuss the just-announced Strategic Alliance with Territory Resources (ASX:TTY) at the Tennant Creek gold projects in Australia's Northern Territory.
ERM EMMRF

 
Emmerson Resources granted halt pending proposed Tennant Creek joint venture agreement

2018-09-03 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) is expecting news of a proposed mining and exploration joint venture agreement at its Tennant Creek projects in the Northern Territory and has been granted a trading halt.
ASXFF ASXFY ERM EMMRF

 
Emmerson Resources on track to drill after promising survey work at Whatling Hill

2018-08-08 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director & CEO Rob Bills updates Proactive Investors on geochemistry sampling results and upcoming milestones at the company’s Whatling Hill discovery within the Fifield project in NSW, Australia.
ERM EMMRF

 
Emmerson Resources soil samples support Whatling Hill copper gold discovery

2018-08-08 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) has received encouraging copper and gold geochemical results at its Whatling Hill Copper Gold prospect within the Fifield Project in New South Wales.
ERM EMMRF

 
Emmerson Resources plans busy September quarter

2018-07-29 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) enters the September quarter after a busy June quarter that produced a high amount of news flow for investors.
ERM EMMRF

 
Emmerson Resources substantial shareholder increases interest through on-market purchases

2018-06-28 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) substantial shareholder Noontide Investments Ltd has increased its holding to 14.8% from 13.5% through a series of on-market transactions.
ERM EMMRF

 
Emmerson Resources adds to gold mine portfolio at Tennant Creek Mineral Field

2018-06-24 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills speaks to Proactive Investors about the latest news from the Tennant Creek Mineral Field, in Australia's Northern Territory. The explorer and producer holds a lot of land in the area, with a number or projects at various stages of development, from early-stage surveying work through to gold bar production.
ERM EMMRF

 
Emmerson Resources drills out mine potential at Mauretania

2018-06-20 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) has received results from initial drilling at Mauretania within the Tennant Creek Mineral Field (TCMF) in the Northern Territory.
ERM EMMRF

3
Emmerson Resources reveals early stage copper-gold discovery in New South Wales

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) has received encouraging results from the first pass fieldwork at the Whatling Hill copper-gold prospect within its Fifield project in New South Wales.
NCMGF NCM NCMGY EVN AMI RRL 3993 CAHPF ERM RGRNF EMMRF

 
Emmerson Resources makes 'a very exciting discovery' at Whatling Hill in NSW

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors about the explorer and producer's discovery of what could be a large porphyry copper system at Whatling Hill; part of the Fifield Project, which in turn is part of the company's exploration portfolio in NSW, Australia.
ERM EMMRF

 
Emmerson Resources makes 'a very exciting discovery' at Wattling Hill in NSW

2018-06-13 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors about the explorer and producer's discovery of what could be a large porphyry copper system at Wattling Hill; part of the Fifield Project, which in turn is part of the company's exploration portfolio in NSW, Australia.
ERM EMMRF

 
'A fantastic step forward' for commercial production at Emmerson Resources

2018-06-12 proactiveinvestors.com.au
Emmerson Resources Ltd (ASX:ERM) managing director Rob Bills tells Proactive Investors all the details of the explorer and producer's recent agreement with Territory Resources Ltd (ASX:TTY).
ERM EMMRF

 
Alliance to develop Tennent Creek processing hub

2018-05-31 australianmining.com.au
Emmerson Resources has formed a strategic alliance with Territory Resources that will lead to the development of a processing hub to support small mines near Tennant Creek in the Northern Territory.
ERM EMMRF

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:ERM / EMMERSON RESOURCES LIMITED on message board site Silicon Investor.

GENI: GenesisIntermedia.com Inc GENI: GenesisIntermedia.com Inc GENI: GenesisIntermedia.com Inc Robert Zimmerman, Bob Dylan, Dylan Robert Zimmerman, Bob Dylan, Dylan Robert Zimmerman, Bob Dylan, Dylan
Bush-The Mastermind behind 9/11? Bush-The Mastermind behind 9/11? Bush-The Mastermind behind 9/11? Longer term short term day trades. Longer term short term day trades. Longer term short term day trades.
NWL: Newell Rubbermaid, Inc. NWL: Newell Rubbermaid, Inc. NWL: Newell Rubbermaid, Inc. Qi cybermoney Qi cybermoney Qi cybermoney
Longer-Term Market Trends Longer-Term Market Trends Longer-Term Market Trends Synopsys (SNPS) Steady long term growth Synopsys (SNPS) Steady long term growth Synopsys (SNPS) Steady long term growth
Thermo Electron (TMO) Thermo Electron (TMO) Thermo Electron (TMO) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY) Buckeyu0027s Bottom Bounce Short Term Picks (CDN ONLY)